ALTERRA Post-Approval Study 2021-11
Research payments
$2,371,285
Through program year 2025, $2,371,285 in research payments was reported against ALTERRA Post-Approval Study 2021-11, across 360 payments, paid by Edwards Lifesciences Corporation.
- Paid by
- Edwards Lifesciences Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $569,048 | 105 |
| 2024 | Research | $651,595 | 109 |
| 2023 | Research | $837,077 | 103 |
| 2022 | Research | $313,565 | 43 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Girish Shirali Kansas City, MO Named on 38 payments
- Gareth Morgan Aurora, CO Named on 15 payments
- Aimee Armstrong Columbus, OH Named on 15 payments
- Barry Love New York, NY Named on 15 payments
- Arash Salavitabar Columbus, OH Named on 15 payments
- Srinath Gowda San Antonio, TX Named on 14 payments
- Evan Zahn Los Angeles, CA Named on 11 payments
- Nicola Maschietto Boston, MA Named on 10 payments
- Alexander Javois Oak Lawn, IL Named on 10 payments
- Howaida El Said San Diego, CA Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.